文献速递消化内镜胰腺与胆道疾病

胆囊切除术后变异肝管损伤的内镜治疗长期结局

Long-term outcomes of endoscopic treatment of aberrant hepatic duct injuries after cholecystectomy.
PubMed 文献 · Gastrointest Endosc · 2019-10-17

该回顾性研究纳入1996年至2019年32例因变异肝管损伤接受ERCP的患者,平均随访109.3个月后91%无症状,认为内镜治疗可作为胆囊切除术后变异肝管损伤的有效一线治疗。

要点

  • 内镜治疗变异肝管损伤长期有效,91%患者无症状
  • 孤立性变异肝管狭窄患者均获通畅
  • Strasberg C型损伤再通率达91%

核心结论

  • 胆囊切除术后变异肝管损伤的内镜治疗可视为有效的一线治疗。

研究设计与样本

  • 回顾性研究,纳入1996年1月至2019年3月共32例因变异肝管损伤接受ERCP的患者,平均年龄51.7岁,78%为女性。

主要发现

  • 6例为Strasberg B型,11例为C型,8例为E5型,7例为变异肝管狭窄。
  • 平均每例置入3.7根胆道塑料支架,平均治疗时长6.3个月。
  • 孤立性变异肝管狭窄患者全部获得通畅,B型中1/6(17%)获得通畅,C型中10/11(91%)获得再通。
  • 平均随访109.3±61.2个月后,29/32(91%)无症状;1例因反复胆管炎手术,1例因胆管炎再行内镜治疗,1例间断胆绞痛经低脂饮食控制。

临床怎么用

  • 对胆囊切除术后变异肝管损伤,可优先考虑内镜治疗。

局限性

  • 回顾性设计,样本量小(32例),来自单中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Right aberrant hepatic ducts are an anatomic variant with clinical relevance because of the risk of injury during cholecystectomy. Treatment options for aberrant hepatic duct injuries are not standardized. This study aims to analyze the long-term results of endoscopic treatment of aberrant hepatic duct lesions. METHODS: Patients who underwent ERCP for aberrant hepatic duct lesions were retrospectively identified. Demographic data, type of aberrant duct lesion according to the Strasberg classification, type of treatment (number of plastic stents inserted, treatment duration, and number of ERCPs), and adverse events were recorded. Follow-up was obtained by telephone contact or medical examinations. RESULTS: Between January 1996 and March 2019, 32 patients (78% women, mean age 51.7 years) with aberrant hepatic duct injuries underwent ERCP at our Endoscopy Unit. Six patients had Strasberg type B lesions, 11 patients had type C, and 8 patients had type E5, and 7 patients had a stenosis of the aberrant duct. A mean of 3.7 biliary plastic stents per patient were used; mean treatment duration was 6.3 months. All patients with isolated aberrant duct stenosis and 1 of 6 patients (17%) with type B Strasberg lesions achieved patency. Ten of 11 patients (91%) with type C Strasberg lesions achieved duct recanalization. After a mean follow-up of 109.3 ± 61.2 months, 29 of 32 patients (91%) were asymptomatic; 1 underwent surgery for recurrent cholangitis, 1 received a new endoscopic procedure because of cholangitis, and 1 reported episodic biliary colic without an increase in liver function test values and was successfully managed with a low-fat diet. CONCLUSIONS: An endoscopic approach to aberrant hepatic duct lesions after cholecystectomy can be considered an effective first-line therapy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Tringali A, Massinha P, Schepis T, et al. Long-term outcomes of endoscopic treatment of aberrant hepatic duct injuries after cholecystectomy. Gastrointest Endosc. 2019. PMID: 31629720. doi:10.1016/j.gie.2019.09.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。